Escitalopram Plasma Concentrations in Premenopausal and Postmenopausal Women
- Sponsor
- Eskisehir Osmangazi University
- Study ID
- NCT07259525
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Depression - Major Depressive Disorder
- General Anxiety Disorder
- Menopause
- Therapeutic Drug Monitoring (TDM)
Eligibility Criteria
- Sex
- FEMALE
- Age
- 40 Years - 60 Years
- Healthy Volunteers
- Not accepted
Study Details
This observational cross-sectional case-control study aims to evaluate the effects of menopausal status on escitalopram metabolism in women. The study will include premenopausal and menopausal women aged 40-60 years who are currently receiving escitalopram treatment and have applied to the Psychiatry Clinic of Eskişehir Osmangazi University. The study aims to identify pharmacokinetic differences associated with hormonal status and to investigate their potential clinical implications. Findings from this research are expected to contribute to the development of evidence-based, individualized treatment strategies for women in menopausal transition.
Key Dates
- First listed
- Dec 2, 2025
- Start date
- Jan 31, 2026
- Status verified
- Dec 2025
- Primary completion
- Jan 31, 2028
- Completion
- Jun 30, 2028
Study Design
- Enrollment
- 94 participants (estimated)
Arms
- Arm: Premenopausal WomenWomen aged 40-60 years, premenopausal, diagnosed with major depressive disorder and/or generalized anxiety disorder, and currently receiving escitalopram treatment.
- Arm: Postmenopausal WomenWomen aged 40-60 years, postmenopausal, diagnosed with major depressive disorder and/or generalized anxiety disorder, and currently receiving escitalopram treatment.
Primary Outcome Measure
Dose-Related Plasma Escitalopram Concentrations [ Time Frame: Up to 14 days ]
Central Contacts
- İmran G Yılmaz Karaman, Associate Professor Doctor02222392979
- Tuğçe Doğan, MD02222392979
Find similar trials
Related Studies
- Apple Women's Health StudyRecruiting · Apple Inc. · Boston, Massachusetts
- Autonomic Regulation of Blood Pressure in Premature and Early Menopausal WomenRecruiting · University of Minnesota · Minneapolis, Minnesota
- Hot Flashes and Neurovascular Function in WomenRecruiting · Mayo Clinic · Rochester, Minnesota
- The Cardiovascular Impact of Hot FlushesRecruiting · University of Minnesota · Minneapolis, Minnesota